Heterogeneity of cancer-Initiating cells within glioblastoma

Frontiers in Bioscience - Scholar

Volumn 4 S, Issue 4, 2012, Pages 1235-1248

  Binda, Elena ^a,b   Visioli, Alberto ^a,b   Reynolds, Brent ^c   Vescovi, Angelo Luigi ^a,b,d  

^a StemGen SpA   (Italy)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^d CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

Author keywords

Brain tumors; Cancer stem like tumor initiating cells; Cancer therapy; Glioblastoma multiforme; Molecular markers; Review

Indexed keywords

BONE MORPHOGENETIC PROTEIN 4; IMATINIB; INTERLEUKIN 13; STAT3 PROTEIN; TEMOZOLOMIDE; THYMIDINE KINASE; TRANSCRIPTION FACTOR GATA 6;

ARTICLE; ASTROCYTOMA; CANCER RECURRENCE; CANCER STEM CELL; CELL HETEROGENEITY; CYTOLOGY; DISEASE CLASSIFICATION; GENE THERAPY; GENETIC HETEROGENEITY; GLIOBLASTOMA; GLIOMA; HUMAN; MOLECULARLY TARGETED THERAPY; NEURAL STEM CELL; NONHUMAN; TUMOR GROWTH; ANIMAL; BRAIN TUMOR; CELL TRANSFORMATION; PATHOLOGY; REVIEW;

ANIMALS; BRAIN NEOPLASMS; CELL TRANSFORMATION, NEOPLASTIC; GLIOBLASTOMA; HUMANS; NEOPLASTIC STEM CELLS;

EID: 84869418869     PISSN: 19450516     EISSN: 19450524     Source Type: Journal    
DOI: None     Document Type: Article

References (150)

1. Craig R. Miller, Arie Perry: Glioblastoma. Arch Pathol Lab Med 131, 397-406 (2007)
2. Julie M. Legler, Lynn A. Ries, Malcolm A. Smith, Joan L. Warren, Ellen F. Heineman, Richard S. Kaplan, Martha S. Linet: Cancer surveillance series [corrected]: brain and other central nervous system cancers: recent trends in incidence and mortality. J Natl Cancer Inst 1999 91, 1382-90 (1999) (Pubitemid 29399996)
3. Kenneth R. Hess, Kristine R. Broglio, Melissa L. Bondy: Adult glioma incidence trends in the United States, 1977-2000. Cancer 101, 2293-9 (2004) (Pubitemid 39458686)
4. Eric C. Burton, Michael D. Prados: Malignant gliomas. Curr Treat Options Oncol 1, 459-68 (2000).
5. Davide Schiffer, Paola Cavalla, Anna Dutto, Lucia Borsotti: Cell proliferation and invasion in malignant gliomas. Anticancer Res 17, 61-9 (1997) (Pubitemid 27116646)
6. Anthony Behin, Khe Hoang-Xuan, Antoine F. Carpentier, Jean-Yves Delattre: Primary brain tumors in adults. Lancet 361, 323-331 (2003)
7. Faith G. Davis, Sally Freels, James Grutsch, Suna Barlas, Steven Brem: Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: an analysis based on Surveillance, Epidemiology, and End Results (SEER) data, 1973-1991. J Neurosurg 88, 1-10 (1998)
8. Dietmar Krex, Barbara Klink, Christian Hartmann, Andreas von Deimling, Torsten Pietsch, Matthias Simon, Michael Sabel, Joachim P. Steinbach, Oliver Heese, Guido Reifenberger, Michael Weller, Gabriele Schackert: Longterm survival with glioblastoma multiforme. Brain 130, 2596-606 (2007)
9. Adam S. Garden, Moshe H. Maor, W. K. Alfred Yung, Janet M. Bruner, Shiao Y. Woo, Richard P. Moser, Ya-Yen Lee: Outcome and patterns of failure following limitedvolume irradiation for malignat astrocytomas. Radiother Oncol 20, 99-110 (1991)
10. Elizabeth A. Maher, Frank B. Furnari, Robert M. Bachoo, David H. Rowith, David. N. Louis, Webster K. Cavenee, Ronald A. DePinho: Malignant glioma: genetics and biology of a grave matter. Genes Dev 15,1311-33 (2001) (Pubitemid 32524640)
11. John W. Henson: Treatment of glioblastoma multiforme: a new standard. Arch Neurol 63, 337-41 (2006)
12. James G. Gurney, Nina Kadan-Lottock: Brain and other central nervous system tumors: rates, trends, and epidemiology. Curr Opin Oncol 13, 160-6 (2003)
13. Fred G. Barker, Susan M. Chang, Philip H. Gutin, Mary K. Malec, Michael W. McDermott, Michael. D. Prados, Charles B. Wilson: Survival and functional status after resection of recurrent glioblastoma multiforme. Neurosurgery 42, 709-20 (1998)
14. Dasarahally S. Mohan, John H. Suh, Jennifer L. Phan, Patrick A. Kupelian, Bruce H. Cohen, Gene H. Barnett: Outcome in elderly patients undergoing definitive surgery and radiation therapy for supratentorial glioblastoma multiforme at a tertiary care institution. Int J Radiat Oncol Biol Phys 42, 981-7 (1998) (Pubitemid 29004138)
15. David A. Reardon, Jeremy N. Rich, Henry S. Friedman, Darell D. Bigner: Recent advances in the treatment of malignant astrocytoma. J. Clin Oncol 24, 1253-65 (2006) (Pubitemid 46622028)
16. Brian J. Huntly, D. Gary Gilliand: Cancer biology: summing up cancer stem cells. Nature 435, 1169-70 (2005) (Pubitemid 40943069)
17. Michael F. Clarke, Margaret Fuller: Stem cells and cancer: two faces of eve. Cell 124, 1111-5 (2006)
18. Stephen W. Coons, Peter C. Johnson, Bernd W. Scheithauer, Allan J. Yates, Dennis K. Pearl: Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas. Cancer 79, 1381-93 (1997) (Pubitemid 27143246)
19. Justin S. Smith, Robert B. Jenkins: Genetic alterations in adult diffuse glioma: occurrence, significance, and prognostic implications. Front Biosci 5, 213-31 (2000)
20. Eran Segal, Nir Friedman, Naftali Kaminski, Aviv Regey, Daphne Koller: From signatures to models: understanding cancer using microarrays. Nat Genet 37, S38-45 (2005) (Pubitemid 40770402)
21. Chand Khanna, Lee J. Helman: Molecular approaches in pediatric oncology. Annu Rev Med 57,83-97 (2006). (Pubitemid 43261980)
22. Markus J. Riemenschneider, Guido Reifenberger: Molecular neuropathology of gliomas. Int J Mol Sci 10, 184-212 (2009)
23. Erik P. Sulman, Marisol Guerrero, Ken Aldape: Beyond grade: molecular pathology of malignant gliomas. Semin Radiat Oncol 19, 142-9 (2009)
24. Frank B. Furnari, Tim Fenton, Robert M. Bachoo, Akitake Mukasa, Jayne M. Stommel, Alexander Stegh, William C. Hahn, Keith L. Ligon, David N. Louis, Cameron Brennan, Lynda Chin, Ronald A. DePinho, Webster K. Cavenee: Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev 21, 2683-710 (2007) (Pubitemid 350070717)
25. Hiroko Ohgaki, Paul Kleihues: Genetic pathways to primary and secondary glioblastoma. Am J Pathol 170, 1445-53 (2007) (Pubitemid 47339290)
26. Patrick Y. Wen, Santosh Kesari: Malignant gliomas in adults. N Engl J Med 359, 492-507 (2008)
27. Deepak Kamnasaran, Baoping Qian, Cynthia Hawkins, William L. Stanford, Abhijit Guha: GATA6 is an astrocytoma tumor suppressor gene identified by gene trapping of mouse glioma model. Proc Natl Acad Sci USA 104, 8053-8 (2007) (Pubitemid 47185874)
28. Maria S. Carro, Wei K. Lim, Mariano J. Alvarez, Robert J. Bollo, Xudong Zhao, Evan Y. Snyder, Erik P. Sulman, Sandrine L. Anne, Fiona Doetsch, Howard Colman, Anna Lasorella, Ken Aldape, Andrea Califano, Antonio Iavarone: The transcriptional network for mesenchymal transformation of brain tumours. Nature 463, 318-25 (2010)
29. Lesley A. Stewart: Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials. Lancet 359, 1011-8 (2002) (Pubitemid 34286538)
30. Charles G. Gross: Neurogenesis in the adult brain: death of a dogma. Nat Rev Neurosci 1, 67-73 (2000)
31. Brent A. Reynolds, Samuel Weiss: Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 255, 1707-10 (1992)
32. Fred H. Gage: Mammalian neural stem cells. Science 287, 1433-8 (2000) (Pubitemid 30127128)
33. Andreas Ardvidsson, Tove Collin, Deniz Kirik, Zaal Kokaia, Olle Lindvall: Neuronal replacement from endogenous precursors in the adult brain after stroke. Nat Med 8, 963-70 (2002) (Pubitemid 35033700)
34. Angelo L. Vescovi, Rossella Galli, Brent A. Reynolds: Brain tumor stem cells. Nat Rev Cancer 6, 425-36 (2006)
35. Tim Demuth, Jessica L. Rennert, Dominique B. Hoelzinger, Linsey. B. Reavie, Mitsutoshi Nakada, Christian. Beaudry, Satoko Nakada, Eric M. Anderson, Amanda N. Henrichs, Wendy S. McDonough, David Holz, Anna Joy, Richard Lin, Kuang H. Pan, Chih J. Lih, Stan N. Cohen, Michael E. Berens: Glioma cells on the run - the migratory transcriptome of 10 human glioma cell lines. BMC Genomics 2008 9, 54 (2008)
36. Jing Li, Clifford Yen, Danny Liaw, Katrina Podsypanina, Shikha Bose, Steven I. Wang, Janusz Puc, Christa Miliaresis, Linda Rodgers, Richard McCombie, Sandra H. Bigner, Beppino C. Giovanella, Michael Ittmann, Ben Tycko, Hanina Hibshoosh, Michael H. Wigler, Ramon Parsons: PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275, 1943-7 (1997) (Pubitemid 27148818)
37. Ingo K. Mellinghoff, Maria Y. Wang, Igor Vivanco, Daphne A. Haas-Kogan, Shaojun Zhu, Ederlyn Q. Dia, Kan V. Lu, Koji Yoshimoto, Julie H. Huang, Dennis J. Chute, Bridget L. Riggs, Steve Horvath, Linda M. Liau, Webster K. Cavenee, P. Nagesh Rao, Rameen Beroukhim, Timothy C. Peck, Jeffrey C. Lee, William R. Sellers, David Stokoe, Michael Prados, Timothy F. Cloughesy, Charles L. Sawyers, Paul S. Mischel: Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors. N Engl J Med 353, 2012-24 (2005) (Pubitemid 41609094)
38. Jayne M. Stommel, Alec C. Kimmelman, Haogiang Ying, Roustem Nabioullin, Aditya H. Ponugoti, Ruprecht Wiedemeyes, Alexander H. Stegh, James E. Bradner, Keith. L. Ligon, Cameron Brennan, Lynda Chin, Ronald A. DePinho: Coactivation of receptor tyrosine kinases affects the response of tumor cells to targeted therapies. Science 318, 287-90 (2007) (Pubitemid 47574858)
39. Sith Sathornsumetee, David A. Reardon, Annick Desjardins, Jennifer A. Quinn, James J. Vredenburgh, Jeremy N. Rich: Molecularly targeted therapy for malignant glioma. Cancer 110, 13-24 (2007)
40. Jeremy N. Rich, Darell D. Bigner: Development of novel targeted therapies in the treatment of malignant glioma. Nat Rev Drug Discov 3, 430-46 (2004) (Pubitemid 38618125)
41. Edward G. Shaw, Robin Rosdhal, Ralph B. D'Agostino Jr, James Lovato, Michelle J. Naughton, Michael E. Robbins, Stephen R. Rapp: Phase II study of donepezil in irradiated brain tumor patients: effect on cognitive function, mood, and quality of life. J Clin Oncol 24, 1415-20 (2006) (Pubitemid 46622007)
42. Hiroyuki Momota, Edward Nerio, Eric C. Holland: Perifosine inhibits multiple signaling pathways in glial progenitors and cooperates with temozolomide to arrest cell proliferation in gliomas in vivo. Cancer Res 65, 7429-35 (2005) (Pubitemid 41161277)
43. Evanthia Galanis, Jan C. Buckner, Matthew J. Maurer, Jeffrey I. Kreisberg, Karla Ballman, J. Boni, Joseph M. Peralba, Robert B. Jenkins, Shaker R. Dakhil, Roscoe F. Morton, Kurt A. Jaeckle, Bernd W. Scheithauer, Janet Dancey, Manuel Hidalgo, Daniel J. Walsh: Phase II trial of temsirolimus (CCI-779) in recurrent glioblastoma multiforme: a North Central Cancer Treatment Group Study. J Clin Oncol 23, 5294-304 (2005) (Pubitemid 46206983)
44. Alba A. Brandes, Mario Ermani, Sergio Turazzi, Elvira Scelzi, Franco Berti, Pietro Amistà, Antonino Rotilio, Claudio Licata, Mario V. Fiorentino: Procarbazine and high-dose tamoxifen as a second-line regimen in recurrent high-grade gliomas: a phase II study. J Clin Oncol 17, 645-50 (1999) (Pubitemid 29075253)
45. Alexander M. Spence, Richard A. Peterson, Jeffrey D. Scharnhorst, Daniel L. Silbergeld, Robert C. Rostomily: Phase II study of concurrent continuous Temozolomide (TMZ) and Tamoxifen (TMX) for recurrent malignant astrocytic gliomas. J Neurooncol 70, 91-5 (2004) (Pubitemid 39194004)
46. W. Robert Bruce, Henk Van Der Gaag: A quantitative assay for the number of murine lymphoma cells capable of proliferation in vivo. Nature 199,79-80 (1963)
47. Chester Southam, Alexander Brunschwig: Quantitative studies of autotransplantation of human cancer. Cancer 14, 461-463 (1961)
48. Larry M. Weisenthal, Marc E. Lippman: Clonogenic and nonclonogenic in vitro chemosensitivity assay. Cancer Treat Rep 69, 615-32 (1985) (Pubitemid 15031677)
49. Giancarlo Secchi: Cancer chemotherapy. Ann Ital Med Int 5, 288-95 (1990)
50. Douglas E. Mattox, Daniel D. Von Hoff: Culture of human head and neck cancer stem cells using soft agar. Arch Otolaryngol 106, 672-4 (1980) (Pubitemid 10029303)
51. Adi F. Gazdar, Desmond N. Carney, Harvie L. Sims, Alfreda Simmons: Heterotransplantation of small-cell carcinoma of the lung into nude mice: comparison of intracranial and subcutaneous routes. Int J Cancer 28, 777-83 (1981) (Pubitemid 12245903)
52. Ronald N. Buick, Lung J. Chang, Hans A. Messner, Joseph E. Curtis, Ernest A. McCulloch: Self-renewal capacity of leukemic blast progenitor cells. Cancer Res 41, 4849-52 (1981) (Pubitemid 12238103)
53. Tsvee Lapidot, Christian Sirard, Josef Vormoor, Barbara Murdoch, Trang Hoang, Julio Caceres-Cortes, Mark Minden, Bruce Paterson, Michael A. Caligiuri, John E. Dick: A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367, 645-8 (1994) (Pubitemid 24067706)
54. Dominique Bonnet, John E. Dick: Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 3, 730-7 (1997) (Pubitemid 27298715)
55. Liqing Jin, Kristin J. Hope, Qiongli Zhai, Florence Smadia-Joffe, John E. Dick: Targeting of CD44 eradicates human acute myeloid leukemic stem cells. Nat Med 12, 1167-74 (2006) (Pubitemid 44527352)
56. Edward Kavalerchik, Daniel Goff, Catriona. H. Jamieson: Chronic myeloid leukemia stem cells. J Clin Oncol. 26, 2911-5 (2008)
57. Brian J. Druker, Charles L. Sawyers, Hagop Kantarjian, Debra J. Resta, Sofia F. Reese, John M. Ford, Renaud Capdeville, Moshe Talpaz: Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome. N Engl J Med 344, 1038-42 (2001) (Pubitemid 32267973)
58. Tim P. Huges, Jaspal Kaeda, Susan Branford, Zbigniew Rudzki, Andreas Hochhaus, Martee L. Hensley, Insa Gathmann, Ann E. Bolton, Iris C. Van Hoomissen, John M. Goldman, Jerald P. Radich: Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia. N Engl J Med 349, 1423-32 (2003) (Pubitemid 37211057)
59. David J. Barnes, Junio V. Melo: Primitive, quiescent and difficult to kill: the role of non-proliferating stem cells in chronic myeloid leukemia. Cell Cycle 5, 2862-6 (2006) (Pubitemid 44953936)
60. Tatyana N. Ignatova, Valery G. Kukekov, Eric D. Laywell, Oleg N. Suslov, Frank D. Vrionis, Dennis A. Steindler: Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro. Glia 39, 193-206 (2006)
61. Muhammad Al-Hajj, Max S. Wicha, Adalberto Benito-Hernandez, Sean J. Morrison, Michael F. Clarke: Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100, 3983-8 (2003) (Pubitemid 36418143)
62. Houman D. Hemmati, Ichiro Nakano, Jorge A. Lazareff, Michael Masterman-Smith, Daniel H. Geschwind, Marianne Bronner-Fraser, Harley I. Kornblum: Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci USA 100, 15178-83 (2003 (Pubitemid 37518036)
63. Sheila K. Singh, Ian D. Clarke, Mizuhiko Terasaki, Victoria E. Bonn, Cynthia Hawkins, Jeremy Squire, Peter B. Dirks: Identifications of a cancer stem cell in human brain tumors. Cancer Res 63, 5821-8 (2003) (Pubitemid 37187480)
64. Rossella Galli, Elena Binda, Ugo Orfanelli, Barbara Cipelletti, Angela Gritti, Simona De Vitis, Roberta Fiocco, Chiara Foroni, Francesco Dimeco, Angelo L. Vescovi: Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res 64, 7011-21 (2004) (Pubitemid 39331011)
65. Sara G. Piccirillo, Brent A. Reynolds, Nadia Zanetti, Giuseppe Lamorte, Elena Binda, Giovanni Broggi, Henry Brem, Alessandro Olivi, Francesco Dimeco, Angelo L. Vescovi: Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumor-initiating cells. Nature 444, 761-5 (2006) (Pubitemid 44949605)
66. Jeongwu Lee, Svetlana Kotliarova, Yuri Kotliarov, Aiguo Li, Qin Su, Nicholas M. Donin, Sandra Pastorino, Benjamin W. Purow, Neil Christopher, Wei Zhang. John K. Park, Howard A. Fine: Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 9, 391-403 (2006) (Pubitemid 43668737)
67. Tannishtha Reya, Sean J. Morrison, Michael F. Clarke, Irving L. Weissman: Stem cells, cancer, and cancer stem cells. Nature 414, 105-11 (2001) (Pubitemid 33041634)
68. Costas G. Hadjipanayis, Erwin G. Van Meir: Tumor initiating cells in malignant gliomas: biology and implications for therapy. J Mol Med 87, 363-74 (2009)
69. Xiangpeng Yuan, James Curtin, Yizhi Xiong, Gentao Liu, Sebastian Waschsmann-Hogiu, Daniel L. Farkas, Keith L. Black, John S. Yu: Isolation of cancer stem cells from adult glioblastoma multiforme. Oncogene 23, 9392-400 (2004) (Pubitemid 40069671)
70. Sara G. Piccirillo, Angelo L. Vescovi: Brain tumor stem cells: possibilities of new therapeutic strategies. Expert Opin Biol Ther 7, 1129-35 (2007) (Pubitemid 47307261)
71. Sheila K. Singh, Cynthia Hawkins, Ian D. Clarke, Jeremy A. Squire, Jane Bayani, Takuichiro Hide, R. Mark Henkelman, Michael D. Cusimano, Peter B. Dirks: Identification of human brain tumor initiating cells. Nature 432, 396-401 (2004) (Pubitemid 39551674)
72. Dominique Boivin, David Labbé, Nicolas Fontaine, Sylvie Lamy, Edith Beaulieu, Denis Gingras, Richard Béliyeau: The stem cell marker CD133 (prominin-1) is phosphorylated on cytoplasmic tyrosine-828 and tyrosine-852 by Src and Fyn tyrosine kinases. Biochemestry 2009 48, 3998-4007 (2009)
73. Urban Lendahl, Lyle B. Zimmerman, Ronald D. McKay: CNS stem cells express a new class of intermediate filament protein. Cell 60, 585-95 (1990)
74. Mila Komitova, Peter S. Eriksson: Sox-2 is expressed by neural progenitors and astroglia in the adult rat brain. Neurosci Lett 369, 24-7 (2004) (Pubitemid 39369496)
75. Shin-ichi Sakakibara, Takao Imai, Kayoko Hamaguchi, Masataka Okabe, Jun Aruga, Kazunori Nakajima, Daisuke Yasutomi, Takashi Nagata, Yasuyuki Kurihara, Seiichi Uesugi, Takaki Miyata, Masaharu Ogawa, Katsuhiko Mikoshiba, Hideyuki Okano: Mouse-Musashi-1, a neural RNA-binding protein highly enriched in the mammalian CNS stem cell. Dev Biol 176, 230-42 (1996) (Pubitemid 26202815)
76. Shideng Bao, Qiulian Wu, Roger E. McLendon, Yueling Hao, Qing Shi, Anita B. Hielmeland, Mark W. Dewhirst, Darell D. Bigner, Jeremy N. Rich: Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444, 756-60 (2006) (Pubitemid 44949604)
77. Ed R. Blazek, Jennifer L. Foutch, Guitta Maki: Daoy medulloblastoma cells that express CD133 are radioresistant relative to CD133-cells, and the CD133+ sector is enlarged by hypoxia. Int J Radiat Oncol Biol Phys 67, 1-5 (2007) (Pubitemid 44959518)
78. Gentao Liu, Xiangpeng Yuan, Zhaohui Zeng, Patrizia Tunici, Hiushan NG, Iman R. Abdulkadir, Lizhi Lu, Dwain Irvin, Keith L. Black, John S. Yu: Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma. Mol Cancer 5, 67 (2006)
79. Jian Wang, Per Ø. Sakariassen, Oleg Tsinkalovsky, Heike Immervoll, Stig O. Bøe, Agnete Svendsen, Lars Prestegarden, Gro Røsland, Frits Thorsen, Linda Stuhr, Anders Molven, Rolf Bjerkvig, Per Ø. Enger: CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells. Int J Cancer 122, 761-8 (2008)
80. Alfred T. Ogden, Allen E. Waziri, Richard A. Lochhead, David Fusco, Kim Lopez, Jason A. Ellis, Joann Kang, Marcela Assanah, Guy M. McKhann, Michael B. Sisti, Paul C. McCormick, Peter Canoll, Jeffrey N. Bruce: Identification of A2B5+CD133-tumor-initiating cells in adult human gliomas. Neurosurgery 62, 505-14 (2008) (Pubitemid 351489297)
81. Dagmar Beier, Peter Hau, Martin Proescholdt, Annette Lohmeier, Jörg Wischhusen, Peter J. Oefner, Ludwig Aigner, Alexander Brawanski, Ulrich Bogdahn, Christoph P. Beier: CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res 67, 4010-5 (2007) (Pubitemid 46815044)
82. Steven M. Pollard, Koichi Yoshikawa, Ian D. Clarke, Davide Danovi, Stefan Stricker, Roslin Russell, Jane Bavani, Renee Head, Marco Lee, Mark Bernstein, Jeremy A. Squire, Austin Smith, Peter B. Dirks: Glioma stem cell lines expanded in adherent culture have tumorspecific phenotypes and are suitable for chemical and genetic screens. Cell Stem Cell 4, 568-80 (2009)
83. Virginie Clément, Valérie Dutoit, Denis Marino, Pierre-Yves Dietrich, Ivan Radovanovic: Limits of CD133 as a marker of glioma self-renewing cells. Int J Cancer 125, 244-8 (2009)
84. Alexandra Capela, Sally Temple: LeX/ssea-1 is expressed by adult mouse CNS stem cells, identifying them as nonependymal. Neuron 35, 865-875 (2002)
85. Alexandra Capela, Sally Temple: LeX is expressed by principle progenitor cells in the embryonic nervous system, is secreted into their environment and binds Wnt-1. Dev Biol 291, 300-313 (2006)
86. Myung J. Son, Kevin Woolard, Do-Hyun Nam, Jeongwu Lee, Howard A. Fine: SSEA-1 is an enrichment marker for tumor-initiating cells in human glioblastoma. Cell Stem Cell 4, 440-52 (2009)
87. Lyle Zimmerman, Urban Lendahl, Miles Cunningham. Ron McKay, Brian Parr, Brian Gavin, Jeff Mann, Galya Vassileva and Andrew McMahon: Independent regulatory elements in the nestin gene direct transgene expression to neural stem cells or muscle precursors. Neuron 12, 11-24 (1994) (Pubitemid 24044383)
88. Jonas Dahlstrand, V. Peter Collins and Urban Lendahl: Expression of the class VI intermediate filament nestin in human central nervous system tumors. Cancer Res 52, 5334-41 (1992)
89. Per M. Almqvist, Richard Mah, Urban Lendahl, Bjorn Jacobsson, Glenda Hendson: Immunohistochemical Detection of Nestin in Pediatric Brain Tumors. J Histochem Cytochem 50, 147-58 (2002) (Pubitemid 34106754)
90. Tadej Strojnik, Gro Vatne Røsland, Per Oystein Sakariassen, Rajko Kavalar and Tamara Lah: Neural stem cell markers, nestin and musashi proteins, in the progression of human glioma: correlation of nestin with prognosis of patient survival. Surg Neurol 68, 133-43 (2007) (Pubitemid 47087905)
91. Sharon K. Thomas, Conrad A. Messam, Barbara A. Spengler, June L. Biedler and Robert A. Ross: Nestin Is a Potential Mediator of Malignancy in Human Neuroblastoma Cells. J Biol Chem 279, 27994-9 (2004) (Pubitemid 38900069)
92. Seiji Hitoshi, Tania Alexson, Vincent Tropepe, Dorit Donoviel, Andrew J. Elia, Jeffrey S. Nye, Ronald A. Conlon, Tak W. Mak, Alan Bernstein and Derek van der Kooy: Notch pathway molecules are essential for the maintenance, but not the generation, of mammalian neural stem cells. Genes & Dev 16, 846-858 (2002) (Pubitemid 34280108)
93. Seiji Hitoshi, Raewyn M. Seaberg, Cheryl Koscik, Tania Alexson, Susumu Kusunoki, Ichiro Kanazawa, Shoji Tsuji and Derek van der Kooy: Primitive neural stem cells from the mammalian epiblast differentiate to definitive neural stem cells under the control of Notch signaling. Genes & Dev 18, 1806-1811 (2004) (Pubitemid 39025091)
94. Spyros Artavanis-Tsakonas, Matthew D. Rand and Robert J. Lake: Notch Signaling: Cell Fate Control and Signal Integration in Development. Science 284, 770-6 (1999) (Pubitemid 29291335)
95. Anjali Shiras, Sivarajan T. Chettiar, Varsha Shepal, Ganeshkumar Rajendran, G. Rajendra Prasad, Padma Shastry: Spontaneous Transformation of Human Adult Nontumorigenic Stem Cells to Cancer Stem Cells Is Driven by Genomic Instability in a Human Model of Glioblastoma. Stem Cells 25, 1478-89 (2007) (Pubitemid 47106016)
96. Xue-Ping Zhang, Gang Zheng, Lian Zou, Hui-Ling Liu, Li-Hong Hou, Peng Zho, Dan-Dan Yin, Qi-Jun Zheng, Liang Liang, Su-Zhen Zhang, Lei Feng, Li-Bo Yao, An-Gang Yang, Hua Han, Jing-Yuan Chen: Notch activation promotes cell proliferation and the formation of neural stem cell-like colonies in human glioma cells. Mol Cell Biochem 307, 101-8 (2008) (Pubitemid 350238652)
97. Xing Fan, William Matsui, Leila Khaki, Duncan Stearns. Jiong Chun, Yue-Ming Li and Charles G. EberhartExpand+: Notch Pathway Inhibition Depletes Stem-like Cells and Blocks Engraftment in Embryonal Brain Tumors. Cancer Res 66, 7445-52 (2006) (Pubitemid 44289197)
98. Rosaria Gangemi, Laura Paleari, Anna Maria Orengo, Alfredo Cesario, Leonardo Chessa, Silvano Ferrini. Patrizia Russo: Cancer stem cells: a new paradigm for understanding tumor growth and progression and drug resistance. Curr Med Chem 16, 1688-703 (2009)
99. In-kyung Park, Dalong Qian, Mark Kiel, Michael W. Becker, Michael Pihalja, Irving L. Weissman, Sean J. Morrison & Michael F. Clarke: Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature 423, 302-5 (2003) (Pubitemid 40852701)
100. Keith L. Ligon, John A. Alberta, Alvin T. Kho, Jennifer Weiss, Mary R. Kwaan, Catherine L. Nutt, David N. Louis, Charles D. Stiles and David H. Rowitch: The oligodendroglial lineage marker OLIG2 is universally expressed in diffuse gliomas. J Neuropathol Exp Neurol 63, 499-509 (2004) (Pubitemid 38669670)
101. Keith L. Ligon, Emmanuelle Huillard, Shwetal Mehta, Santosh Kesari, Hongye Liu, John A. Alberta, Robert M. Bachoo, Michael Kane, David N. Louis, Ronald A. DePinho, David J. Anderson, Charles D. Stiles and David H. Rowitch: Olig2-regulated lineage-restricted pathway controls replication competence in neural stem cells and malignant glioma. Neuron 53, 503-17 (2007) (Pubitemid 46216748)
102. Ichiro Nakano, Michael Masterman-Smith, Kuniyasu Saigusa, Andres A. Paucar, Steve Horvath, Lorelei, Shoemaker, Momoko Watanabe, Alejandra Negro, Ruchi Bajpai, Amy Howes, Vincent Lelievre, James A. Waschek, Jorge A. Lazareff, William A. Freije, Linda M. Liau, Richard J. Gilbertson, Timothy F. Cloughesy, Daniel H. Geschwind, Stanley F. Nelson, Paul S. Mischel, Alexey V. Terskikh, Harley I. Kornblum: Maternal embryonic leucine zipper kinase is a key regulator of the proliferation of malignant brain tumors, including brain tumor stem cells. J Neurosci Res 86, 48-60 (2008)
103. Margot Zöller: CD44: can a cancer-initiating cell profit from an abundantly expressed molecule? Nat Rev Cancer 11, 254-67 (2011)
104. Piero Dalerba, Scott J. Dylla, In-Kyung Park, Rui Liu, Xinhao Wang, Robert W. Cho, Timothy Hoey, Austin Gurney, Emina H. Huang, Diane M. Simeone, Andrew A. Shelton, Giorgio Parmiani, Chiara Castelli and Michael F. Clarke: Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci USA 104, 10158-63 (2007) (Pubitemid 47175279)
105. Stella Maris Ranuncolo, Virginia Ladeda, Sergio Specterman, Mirta Varela, José Lastiri, Ana Morandi, Elena Matos, Elisa Bal De Kier Joffe. Lydia Puricelli, Maria Guadalupe Pallotta: CD44 expression in human gliomas. J Surg Oncol 79, 30-5 (2002) (Pubitemid 34049541)
106. Judit Anido, Andrea Sàez-Borderias, Alba Gonzalez-Juncà, Laura Rodon, Gerard Folch, Maria A. Carmona. Rosa M. Prieto-Sanchez, Ignasi Barba, Elena Martinez-Saez, Ludmilla Prudkin, Isabel Cuartas, Carolina Raventos, Francisco Martinez-Ricarte, M. Antonia Poca, David Garcia-Dorado, Michael M. Lahn, Jonathan M. Yingling, Jordi Rodon, Juan Sahuquillo, Josè Baselga and Joan Seoane: TGF-β Receptor Inhibitors Target the CD44high/Id1high Glioma-Initiating Cell Population in Human Glioblastoma. Cancer Cell 18, 655-68 (2010)
107. Rachid Marhaba, Pamela Klingbeil. Tobias Nuebel. Irina Nazarenko, Markus W. Buechler, Margot Zoeller: CD44 and EpCAM: cancer-initiating cell markers. Curr Mol Med 8, 784-804 (2008)
108. Marzenna Wiranowska, Sharron Ladd, Sarice R. Smith and Paul E. Gottschall: CD44 adhesion molecule and neuroglial proteoglycan NG2 as invasive markers of glioma. Brain Cell Biol 35, 159-72 (2006) (Pubitemid 47630628)
109. Virginie Clément, Denis Marino, Cristina Cudalbu, Marie-France Hamou, Vladimir Mlynarik, Nicolas de Tribolet, Pierre-Yves Dietrich, Rolf Gruetter, Monika E. Hegi and Ivan Radavanovic: Marker-indipendent identification of gliomainitiating cells. Nat Methods 7, 224-8 (2010)
110. Mina Kim, Cindi M. Morshead: Distinct populations of forebrain neural stem and progenitor cells can be isolated using side-population analysis. J Neurosci 23, 10703-9 (2003) (Pubitemid 37485284)
111. Rodney L. Rietze, Helen Valcanis, Gordon F. Brooker, Tim Thomas, Anne K. Voss, Perry F. Bartlett: Purification of a pluripotent neural stem cell from the adult mouse brain. Nature 412, 736-9 (2001) (Pubitemid 32771996)
112. Tzu-Ting Huang, Shawn M. Sarkaria, Timothy F. Cloughesy, Paul S. Mischel: Targeted therapy for malignat glioma patients: lessons learned and the road ahead. Neurotherapeutics 6, 500-12 (2009)
113. Florence Lefranc, Michal Rynkowski, Olivier DeWitte, Robert Kiss: Present and potential future adjuvant issues in high-grade astrocytic glioma treatment. Adv Tech Stand Neurosurg 34, 3-35 (2009)
114. Peter C. Burger, Flôres S. Vogel, Sonya B. Green, Thomas A. Strike: Glioblastoma multiforme and anaplastic astrocytoma. Pathologic criteria and prognostic implications. Cancer 56, 1106-11 (1985) (Pubitemid 15003495)
115. Shekar N. Kurpad, Henry S. Friedman, Gary E. Archer, Roger E. McLendon, William M. Petros, Herbert E. Fuchs, Al Guaspari, Darell D. Bigner: Intraarterial administration of melphalan for treatment of intracranial human glioma xenografts in athymic rats. Cancer Res 55, 3803-9 (1995)
116. William W. Vick, Carol J. Wikstrand, Dennis E. Bullard, John T. Kemshead, Hugh B. Coakham, Jeffrey Schlom, William W. Johnston, Darell D. Bigner, Sandra H. Bigner: The use of a panel of monoclonal antibodies in the evaluation of cytologic specimens from the central nervous system. Acta Cytol 31, 815-24 (1987) (Pubitemid 18007934)
117. Gheeyoung Choe, Steve Horvath, Timothy F. Cloughesy, Katherine Crosby, David Seligson, Aarno Palotie, Landon Inge, Bradley L. Smith, Charles L. Sawyesrs, Paul S. Mischel: Analysis of the phosphatidylinositol 3'-kinase signaling pathway in glioblastoma patients in vivo. Cancer Res 63, 2742-46 (2003) (Pubitemid 36667143)
118. Arnab Chakravarti, Gary Zhai, Yoshiyuki Suzuki, Sormeh Sarkesh, Peter M. Black, Alona Muzikansky, Jay S. Loeffler: The prognostic significance of phosphatidylinositol 3-kinase pathway activation in huma gliomas. J Clin Oncol 22, 1926-33 (2004) (Pubitemid 41095185)
119. Max Chaffanet, Christiane Chauvin, Michèle Lainé, François Berger, Monique Chédin, Nathalie Rost, Marie-France Nissou, Alim L. Benabid: EGF receptor amplification and expression in human brain tumours. Eur J Cancer 28, 11-7 (1992)
120. Timothy P. Fleming, Abha Saxena, W. Craig Clark, James T. Robertson, Edward H. Oldfield, Stuart A. Aaronson, Iqbal Unnisa Ali: Amplification and/or overexpression of platelet-derived growth factor receptors and epidermal growth factor receptor in human glial tumors. Cancer Res 52, 4550-3 (1992)
121. Robert C. Rostomily, G. Evren Keles, Mitchel S. Berger: Radical surgery in the management of low-grade and highgrade gliomas. Baillieres Clin Neurol 5, 345-69 (1996)
122. Michael D. Walker, Eben J. Alexander, William E. Hunt, Collin S. MacCarty, M. Stephen J. Mahaley, John J. Mealey, Horace A. Norrell, Guy Owens, Joseph Ransohoff, Charles B. Wilson, Edmund A. Gehan, Thomas A. Strike: Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial. J Neurosurg 49, 333-343 (1978) (Pubitemid 9013313)
123. Michael D. Walker, Sylvan B. Green, David P. Byar, Eben Alexander Jr, Ulrich Batzdorf, William H. Brooks, William E. Hunt, Collin S. MacCarty, M. Stephen Mahaley Jr, John Mealey Jr, Guy Owens, Joseph Ransohoff 2nd, James T. Robertson, William R. Shapiro, Kenneth R. Smith Jr, Charles B. Wilson, Thomas A. Strike: Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Engl J Med 303, 1323-9 (1980) (Pubitemid 11194457)
124. Maria Geraldina Castro, Rachel Cowen, Ian K. Williamson, Alexandria David, Maximiliano J. Jimenez-Dalmaroni, Xiuqin Yuan, Alireza Bigliari, Julie C. Williams, Jianying Hu, Pedro R. Lowenstein: Current and future strategies for the treatment of malignant brain tumors. Pharmacol Ther 98, 71-108 (2003) (Pubitemid 36349762)
125. Peter B. Dirks: Cancer: stem cells and brain tumours. Nature 444, 687-8 (2006) (Pubitemid 44949580)
126. Nigel P. Mongan, Lorraine J. Gudas: Diverse actions of retinoid receptors in cancer prevention and treatment. Differentiation 75, 853-70 (2007) (Pubitemid 350086170)
127. Rihab Nasr, Marie-Claude Guillemin, Omar Ferhi, Hassan Soilihi, Laurent Peres, Caroline Berthier, Philippe Rousselot, Macarena Robledo-Sarmiento, Valérie Lallemand-Breitenbach, Bernard Gourmel, Dominique Vitoux, Pier Paolo Pandolfi, Cécile Rochette-Egly, Jun Zhu, Hugues de Thé: Eradication of acute promyelocytis leukemia-initiating cells through PML-RARA degradation. Nat Med 14, 1333-42 (2008)
128. Zhen-Yi Wang, Zhu Chen: Acute promyelocytic leukemia: from highly fatal to highly curable. Blood 111, 2505-15 (2008)
129. Jeongwu Lee, Myung J. Son, Kevin Woolard, Nicholas M. Donin, Aiguo Li, Chui H. Cheng, Svetlana Kotliarova, Yuri Kotliarov, Jennifer Walling, Susie Ahn, Misuk Kim, Mariam Totonchy, Thomas Cusack, Chibawanye Ene, Hilary Ma, Qin Su, Jean Claude Zenklusen, Wei Zhang, Dragan Maric and Howard A. Fine: Epigenetic-mediated dysfunction of the bone morphogenetic protein pathway inhibits differentiation of glioblastoma-initiating cells. Cancer Cell 13, 69-80 (2008) (Pubitemid 350309742)
130. Daniel A. Lim, Anthony D. Tramontin, Jose M. Trevejo, Daniel G. Herrera, Jose M. Garcia-Verdugo, Arturo Alvarez-Buylla: Noggin antagonizes BMP signaling to create a niche for adult neurogenesis. Neuron 28, 713-26 (2000) (Pubitemid 32038066)
131. Prithi Rajan, David M. Panchision, Laura F. Newell, Ronald D. McKay: BMPs signal alternately through a SMAD or FRAP-STAT pathway to regulate fate choice in CNS stem cells. J Cell Biol 161, 911-21 (2003) (Pubitemid 36718424)
132. Dennis R. Groothius: The blood-brain and blood-tumor barriers: a review of strategies for increasing drug delivery. Neuro Oncol 2, 45-59 (2000)
133. Edward A. Neuwelt: Mechanisms of disease: the bloodbrain barrier. Neurosurgery 54, 131-40 (2004)
134. Pauline Breedveld, Jos H. Beijnen, Jan H. Schellens: Use of P-glycoprotein and BCRP inhibitors to improve oral bioavailability and CNS penetration of anticancer drug. Trends Pharmacol Sci 27, 17-24 (2006) (Pubitemid 43063120)
135. Simon Dai, Mary Lin Huang, Chang Y. Hsu, K. S. Clifford Chao: Inhibition of hypoxia inducible factor 1alpha causes oxygen-independent cytotoxicity and induces p53 independent apoptosis in glioblastoma cells. Int J Radiat Oncol Biol Phys 55, 1027-36 (2003) (Pubitemid 36287007)
136. Peter Vajkoczy, Michael D. Menger: Vascular microenvironment in gliomas. Cancer Treat Res 117, 249-62 (2004)
137. Karl H. Plate, Hans D. Mennel: Vascular morphology and angiogenesis in
138. Asao Hirano, Takanori Matsui: Vascular structures in brain tumors. Hum Pathol 6, 611-21 (1975)
139. Don M. Long: Capillary ultrastructure in human metastatic brain tumors. J Neurosurg 51, 53-8 (1979) (Pubitemid 9213249)
140. R. Hunt. Bobo, Douglas W. Laske, Aytac Akbasak, Paul F. Morrison, Robert L. Dedrick, Edward H. Oldfield: Convection-enhanced delivery of macromolecules in the brain. Proc Natl Acad Sci USA 91, 2076-80 (1994) (Pubitemid 24092045)
141. Luisa Barzon, Marco Pacenti, Elisa Franchin, Federico Colombo, Giorgio Palù: HSV-TK/IL-2 gene therapy for glioblastoma multiforme. Methods Mol Biol 542, 529-49 (2009)
142. Federico Colombo, Luisa Barzon, Elisa Franchin, Marco Pacenti, Vittore Pinna, Daniela Danieli, Mariano Zanusso, Giorgio Palù: Combined HSV-TK/IL-2 gene therapy in patients with recurrent glioblastoma multiforme: biological and clinical results. Cancer Gene Ther 12, 835-48 (2005) (Pubitemid 43086285)
143. Sandeep Kunwar, Michael D. Prados, Susan M. Chang, Mitchel S. Berger, Frederick F. Lang, Joseph M. Piepmejer, John H. Sampson, Zvi Ram, Philip H. Gutin, Robert D. Gibbons, Kenneth D. Aldape, David J. Croteau, Jeffrey W. Sherman, Raj K. Puri: Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: a report by the Cintredekin Besudotox Intraparenchymal Study Group. J Clin Oncol 25, 837-44 (2007) (Pubitemid 350002884)
144. Roger Stupp, Warren P. Mason, Martin J. van den Bent, Michael Weller, Barbara Fisher, Martin J. Taphoorn, Karl Belanger, Alba A. Brandes, Christine Marosi, Ulrich Bogdahn, Jürgen Curschmann, Robert C. Janzer, Samuel K. Ludwin, Thierry Gorlia, Anouk Allgeier, Denis Lacombe, J. Gregory Cairncross, Elizabeth Eisenhauer, René O. Mirimanoff: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352, 987-96 (2005) (Pubitemid 40349501)
145. Akio Soeda, Akihito Inagaki, Naoki Oka, Yuka Ikegame, Hitomi Aoki, Shin-ichi Yoshimura, Shigeru Nakashima, Takahiro Kunisada, Toru Iwama: Epidermal growth factor plays a crucial role in mitogenic regulation of human brain tumor stem cells. J Biol Chem 283, 10958-66 (2008)
146. Craig T. Jordan, Monica L. Guzman, Mark Noble: Cancer stem cells. N Engl J Med 355, 1253-61 (2006) (Pubitemid 44427449)
147. Jeremy. N. Rich, Shideng Bao: Chemotherapy and cancer stem cells. Cell Stem Cell 1, 353-5 (2007) (Pubitemid 47506543)
148. Gregor B. Adams, David T. Scadden: A niche opportunity for stem cell therapeutics. Gene Ther 15, 96-9 (2008)
149. Elsa Quintana, Mark Shackleton, Michael S. Sabel, Douglas R. Fullen, Timothy M. Johnson, Sean J. Morrison: Efficient tumour formation by single human melanoma cells. Nature 456, 593-8 (2008)
150. Mikhail V. Blagosklonny: Target for cancer therapy: proliferating cells or stem cells. Leukemia 20, 385-91 (2006) (Pubitemid 43291733)